Table 12.
Outcome | Included studies | Total, n | Certainty of evidence | RR (95% CI); I2 | Absolute difference (95% CI) or mean difference (95% CI); I2 |
---|---|---|---|---|---|
Neonatal mortality | Andersson et al,278 2019 | 231 | Very low | 0.10 (0.01–1.98) | 30/1000 fewer infants (70 fewer–10 more per 1000) died when later (delayed) cord clamping ≥60 s was intended than when later (delayed) cord clamping <60 s was intended |
Hb concentration within 24 h after birth | Katheria et al,282 2017 | 60 | Very low | MD, 1.30 g/dL (0.14–2.46); not available* | |
Hyperbilirubinemia treated with phototherapy | Kc et al,279 2017 Nouraie et al,283 2019 |
906 | Very low | 1.93 (1.00–3.72); 60% | 70/1000 more infants (0–204 more per 1000) had hyperbilirubinemia treated with phototherapy when later cord clamping ≥60 s was intended compared with when later cord clamping <60 s was intended |
Neurodevelopmental outcomes in early childhood | Rana et al,285 2019 | 540 | Very low | 2.3 (1.44–3.78) | 103/1000 more infants (34–216 more per 1000) would have ASQ-3 scores >279 when later cord clamping for ≥60 s was intended compared with when later cord clamping for <60 s was intended |
ASQ-3 indicates Ages & Stages Questionnaire, Third Edition; Hb, hemoglobin; MD, mean difference; and RR, risk ratio.
Only 1 study available.